|
|
Post by ktim on Jan 21, 2020 17:26:22 GMT -5
Seems unfair to omit Dr. Andrea Leone-Bay and RLS from this discussion. She left to become Chief Scientific Officer at RLS but might still be working inside the Mannkind facility. "Andrea Leone-Bay holds a PhD in Organic Chemistry and has worked in the pharmaceutical industry for over 25 years. She has published 45 manuscripts in peer-reviewed journals and is an inventor on 87 issued US patents. Her primary areas of expertise include chemistry and formulations research and development for protein and peptide delivery. Andrea Leone-Bay is a popular speaker at Medical & Pharma, Business Services & Science & Research related events." Maybe all are plotting to eventually join forces  I wonder if Andrea is still working out of the controlled substance laboratory inside MannKind or if RLS has their own place now that they have a CMO & some capital. My guess is the former, but would be nice to know they have scaled things up by now. Would be nice if they registered a Phase I trial. Seems like a 5 year old kid that hasn't taken his first step yet. |
|
|
|
Post by mango on Jan 21, 2020 17:48:23 GMT -5
I wonder if Andrea is still working out of the controlled substance laboratory inside MannKind or if RLS has their own place now that they have a CMO & some capital. My guess is the former, but would be nice to know they have scaled things up by now. Would be nice if they registered a Phase I trial. Seems like a 5 year old kid that hasn't taken his first step yet. They definitely need to get the ball rolling soon. The lack of transparency and information on their side is frustrating to say the least. |
|
|
|
Post by ktim on Jan 21, 2020 17:53:35 GMT -5
Would be nice if they registered a Phase I trial. Seems like a 5 year old kid that hasn't taken his first step yet. They definitely need to get the ball rolling soon. The lack of transparency and information on their side is frustrating to say the least. They are a closely held private company, so the lack of transparency is the ordinary course of business. One wouldn't expect any news until they do file for a Phase I. |
|
|
|
Post by mango on Jan 21, 2020 17:59:18 GMT -5
They definitely need to get the ball rolling soon. The lack of transparency and information on their side is frustrating to say the least. They are a closely held private company, so the lack of transparency is the ordinary course of business. One wouldn't expect any news until they do file for a Phase I. Samumed is a privately held company too, but they have plenty of transparency and information available to the public. RLS doesn’t even have any publications or preclinical studies or anything for that matter, only global news wire PRs. They could put forth a little effort but apparently they have nothing to talk about. May be the “normal behavior” but I don’t care if that’s the status quo, it’s time to make themselves heard. |
|
|
|
Post by letitride on Jan 21, 2020 21:24:36 GMT -5
May be the “normal behavior”
stoners
|
|
